Explore

Trendline Trendline
Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation
Trendline Trendline
Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Amid Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Amid Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Amid Trial Discontinuation
Trendline Trendline
Rosen Law Firm Urges Concorde International Group Investors to Join Securities Class Action

Rosen Law Firm Urges Concorde International Group Investors to Join Securities Class Action

Rosen Law Firm Urges Concorde International Group Investors to Join Securities Class Action
Trendline Trendline
Rosen Law Firm Urges Navan, Inc. Investors to Act Before April 24 Deadline in Securities Class Action

Rosen Law Firm Urges Navan, Inc. Investors to Act Before April 24 Deadline in Securities Class Action

Rosen Law Firm Urges Navan, Inc. Investors to Act Before April 24 Deadline in Securities Class Action
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine for Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Securities Claims Following FDA Rejection
Trendline Trendline
Rosen Law Firm Advises Vital Farms Investors on Class Action Participation

Rosen Law Firm Advises Vital Farms Investors on Class Action Participation

Rosen Law Firm Advises Vital Farms Investors on Class Action Participation
Trendline Trendline
Rosen Law Firm Urges Soleno Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Soleno Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Soleno Therapeutics Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection
Trendline Trendline
Rosen Law Firm Advises Aldeyra Therapeutics Investors on May 29 Deadline in Securities Class Action

Rosen Law Firm Advises Aldeyra Therapeutics Investors on May 29 Deadline in Securities Class Action

Rosen Law Firm Advises Aldeyra Therapeutics Investors on May 29 Deadline in Securities Class Action
Trendline Trendline
Rosen Law Firm Urges ODDITY Tech Ltd Investors to Act Before Securities Class Action Deadline

Rosen Law Firm Urges ODDITY Tech Ltd Investors to Act Before Securities Class Action Deadline

Rosen Law Firm Urges ODDITY Tech Ltd Investors to Act Before Securities Class Action Deadline
Trendline Trendline
Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors

Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors

Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors
Trendline Trendline
Rosen Law Firm Urges Eos Energy Investors to Join Securities Class Action

Rosen Law Firm Urges Eos Energy Investors to Join Securities Class Action

Rosen Law Firm Urges Eos Energy Investors to Join Securities Class Action